ArticleJournal of diabetes investigation2011

Glucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial.

Yutaka Seino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.